Medipharm Labs (Otc) (TSE:LABS) has released an update.
MediPharm Labs Corp., a leader in pharmaceutical-quality cannabinoid manufacturing, has announced it will report its first quarter financial results for 2024 on May 15, before market open. Along with the earnings report, the company’s executive management team will host a conference call and webcast to discuss the results on the same day. The recent acquisition of VIVO Cannabis Inc. has expanded MediPharm’s reach in the medical cannabis markets in Canada, Australia, and Germany.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
